Shandong Sito Bio-technology Co., Ltd.
300583.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.64B
Close$
$-6.18
148.1% downside
Current Fair Value
148.1% downsideOvervalued by 148.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.64 Billion |
|---|---|
| Enterprise Value | $3.11 Billion |
| Dividend Yield | $0.02 (0.11%) |
| Earnings per Share | $-0.39 |
| Beta | 0.11 |
| Outstanding Shares | 197,013,326 |
Return
| Return on Equity | 0.55% |
|---|---|
| Return on Assets | 0.33% |
| Return on Invested Capital | 2.48% |
Valuation & Multiples
| P/E Ratio | 249.64 |
|---|---|
| PEG | -121.37 |
| Price to Sales | 2.57 |
| Price to Book Ratio | 1.43 |
| Enterprise Value to Revenue | 2.77 |
| Enterprise Value to EBIT | 64.11 |
| Enterprise Value to Net Income | 318 |
| Total Debt to Enterprise | 0.23 |
| Debt to Equity | 0.41 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Shandong Sito Bio-technology Co., Ltd.
990 employees
CEO: Qi Mi Shandong Sito Bio-technology Co., Ltd. researches, develops, and produces steroid biomedicine intermediates. Its products include 9a-hydroxyandrost, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, neomycin...